Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEVRH.L Regulatory News (EVRH)

  • There is currently no data for EVRH

Director/PDMR Shareholding

1 Nov 2017 17:11

RNS Number : 3184V
EVR Holdings PLC
01 November 2017
Β 

The information contained within this announcement is deemed by the Company to constitute inside information stipulated under the Market Abuse Regulation (EU) No. 596/2014. Upon the publication of this announcement via the Regulatory Information Service, this inside information is now considered to be in the public domain.

Β 

EVR Holdings plc

("EVR" or the "Company")

Β 

Directors' Shareholdings and PDMR notification

Further to the announcement of 25 October "2017 Proposed Placing to raise Β£10 million for the Company and Β£5 million for selling shareholders", EVR Holdings plc (AIM: EVRH), one of the leading creators of virtual reality content, today announces that certain persons discharging managerial responsibilities (the "Selling Shareholders") have sold, pursuant to the Placing, an aggregate of 62,500,000 ordinary shares in the Company ("Ordinary Shares"), representing approximately 5.4 per cent of the issued share capital of the Company at a price of 8 pence per share.Β 

Β 

Director

Shareholding prior to sale

Shareholding prior to sale (% ISC)

Shareholding post sale

Shareholding post sale (% ISC)

Anthony Matchett

215,357,796

20.88%

184,107,796

15.90%

Steven Hancock

177,759,136

17.24%

146,509,136

12.66%

The Company has been informed that the shares held by the Selling Shareholders following the Placing will be subject to a six-month lock-up in respect of 50 per cent. of those shares and a 12-month lock-up in relation to the remaining 50 per cent., with certain customary exemptions.

Β 

The notification below, made in accordance with the requirements of the EU Market Abuse Regulation, provides further detail.

Β 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Β 

1. Anthony Matchett

2. Steven Hancock

2

Reason for the notification

a)

Position/status

Β 

1. Chief Executive Officer

2. Chief Operations Officer

b)

Initial notification/Amendment

Β 

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

EVR Holdings plc

b)

LEI

213800B2AKGQC3D2R751

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Β 

Identification code

Ordinary Shares of 1 penny each

Β 

ISIN GB00BD2YHN21

b)

Nature of the transaction

Β 

Sale of ordinary shares

c)

Price(s) and volume(s)

Β 

Β 

Price(s)

Volume(s)

1. 8p

31,250,000

2. 8p

31,250,000

d)

Aggregated information

Β 

N/A

e)

Date of the transaction

Β 

27 October 2017

Β 

f)

Place of the transaction

Β 

Β 

London Stock Exchange, AIM

Β 

Β 

For further information:

EVR Holdings plc

Anthony Matchett, Chief Executive Officer

Sebastian Theron, Chief Financial Officer

www.evrholdings.comΒ 

Β 

Zeus Capital Limited (Nominated Adviser and Broker)

Andrew Jones (Corporate Finance)

Tel: +44 (0) 203 829 5000

John Goold / Benjamin Robertson (Sales & Broking)

www.zeuscapital.co.uk

Β 

Β 

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
DSHOKDDDOBDDKDK
Date   Source Headline
21st May 202012:00 pmRNSLive Nation partnership for ‘Wireless Connect’
15th May 20207:00 amRNSMelodyVR launch content studio and 'Live from LA'
11th May 20201:54 pmRNSResult of AGM
4th May 20207:00 amRNSLaunch of 'On stage', a free-to-fan content series
20th Apr 20204:40 pmRNSSecond Price Monitoring Extn
20th Apr 20204:35 pmRNSPrice Monitoring Extension
20th Apr 20202:06 pmRNSSecond Price Monitoring Extn
20th Apr 20202:00 pmRNSPrice Monitoring Extension
20th Apr 202011:06 amRNSSecond Price Monitoring Extn
20th Apr 202011:00 amRNSPrice Monitoring Extension
16th Apr 20205:52 pmRNSHolding(s) in Company
16th Apr 202012:37 pmRNSNotice of AGM and proposed change of name
2nd Apr 20204:41 pmRNSSecond Price Monitoring Extn
2nd Apr 20204:37 pmRNSPrice Monitoring Extension
2nd Apr 20202:06 pmRNSSecond Price Monitoring Extn
2nd Apr 20202:00 pmRNSPrice Monitoring Extension
2nd Apr 20209:05 amRNSSecond Price Monitoring Extn
2nd Apr 20209:00 amRNSPrice Monitoring Extension
1st Apr 20206:27 pmRNSHolding(s) in Company
31st Mar 202012:08 pmRNSHolding(s) in Company
23rd Mar 20203:30 pmRNSSuccessful fundraise of $12 million
23rd Mar 20207:00 amRNSAccelerated bookbuild
20th Mar 20204:45 pmRNSSecond Price Monitoring Extn
20th Mar 20204:40 pmRNSPrice Monitoring Extension
20th Mar 20202:06 pmRNSSecond Price Monitoring Extn
20th Mar 20202:01 pmRNSPrice Monitoring Extension
20th Mar 202011:06 amRNSSecond Price Monitoring Extn
20th Mar 202011:00 amRNSPrice Monitoring Extension
19th Mar 20204:41 pmRNSSecond Price Monitoring Extn
19th Mar 20204:36 pmRNSPrice Monitoring Extension
19th Mar 20202:06 pmRNSSecond Price Monitoring Extn
19th Mar 20202:00 pmRNSPrice Monitoring Extension
19th Mar 202011:05 amRNSSecond Price Monitoring Extn
19th Mar 202011:00 amRNSPrice Monitoring Extension
18th Mar 20204:43 pmRNSSecond Price Monitoring Extn
18th Mar 20204:39 pmRNSPrice Monitoring Extension
18th Mar 20202:06 pmRNSSecond Price Monitoring Extn
18th Mar 20202:01 pmRNSPrice Monitoring Extension
18th Mar 202011:05 amRNSSecond Price Monitoring Extn
18th Mar 202011:00 amRNSPrice Monitoring Extension
18th Mar 20207:00 amRNSCOVID-19 Strategy Update
9th Mar 20202:06 pmRNSSecond Price Monitoring Extn
9th Mar 20202:01 pmRNSPrice Monitoring Extension
9th Mar 202011:06 amRNSSecond Price Monitoring Extn
9th Mar 202011:01 amRNSPrice Monitoring Extension
14th Jan 20205:25 pmRNSHolding(s) in Company
6th Jan 20207:00 amRNSOption Exercise valuing the Company at £220m
5th Dec 20199:49 amRNSMelodyVR extends O2 Partnership
4th Dec 20191:06 pmRNSMelodyVR featured by Google in Best Apps of 2019
21st Nov 201912:00 pmRNSMelodyVR featured by Apple Inc. as App of the Day

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.